Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-09-12)Premium Content

Quest Diagnostics Inc (DGX)

2014-11-26@03:39:41 ET
Global Bioinformatics Market Outlook 2020 for the $12 Billion Industry (MTO)

2014-11-25@12:12:13 ET
Landauer Ranks the Highest in Terms of Dividend Yield in the Health Care Services Industry (LDR, PMD, DGX) (F70)

2014-11-25@11:17:28 ET
Quest Diagnostics (DGX) Showing Bullish Technicals (FBM)

2014-11-24@15:25:36 ET
Recent 52-Week High Exceeded in Shares of Quest Diagnostics (DGX) (F71)

2014-11-24@12:21:52 ET
Quest Diagnostics (DGX) Showing Bullish Technicals With Support At $63.74 (FBM)

2014-11-21@15:45:55 ET
Quest Diagnostics Looks to Continue to Trade Above its Annual-High Share Price Today (F71)

2014-11-21@12:34:59 ET
Quest Diagnostics Shares Climbing Higher, Up 2.0% (F77)

2014-11-21@12:17:34 ET
Highest Forward Earnings Yield in the Health Care Services Industry Detected for Laboratory Corp of America Holdings (LH, AFAM, DGX) (F70)

2014-11-21@11:49:13 ET
Potential Quest Diagnostics (DGX) Trade Has 2.05% Downside Protection (FBM)

2014-11-21@09:17:47 ET
Form 4: Update Filing for Quest Diagnostics Inc (DGX) (VKR)

2014-11-21@08:13:58 ET
HMS Holdings had the Lowest Relative Performance in the Health Care Services Industry (HMSY, LH, OCR, DVA, DGX) (F70)

2014-11-21@07:02:39 ET
Form 4: Update Filing for Quest Diagnostics Inc (DGX) (VKR)

2014-11-20@13:23:21 ET
Quest Diagnostics (DGX) Showing Bullish Technicals With Support At $62.52 (FBM)

2014-11-20@08:19:10 ET
Short-term Underperformance Detected in Shares of RadNet in the Health Care Services Industry (RDNT, HMSY, MD, DGX, BIOS) (F70)

2014-11-19@12:32:54 ET
Quest Diagnostics (DGX) Showing Bullish Technicals With Support At $62.67 (FBM)

2014-11-19@09:47:49 ET
Form 4: Update Filing for Quest Diagnostics Inc (DGX) (VKR)

2014-11-19@09:47:39 ET
Form 4: Update Filing for Quest Diagnostics Inc (DGX) (VKR)

2014-11-18@10:58:10 ET
Quest Diagnostics (DGX) Breaks Through Resistance at $63.38 (F79)

2014-11-18@09:51:00 ET
ACLA Retains Attorneys Paul D. Clement and Laurence H. Tribe To Represent ACLA in Opposing the FDA's Proposal To Treat Laboratory Developed Tests (LDTs) as Medical Devices (PRN)

2014-11-18@08:14:27 ET
Best Relative Performance in the Health Care Services Industry Detected in Shares of Mednax (MD, ESRX, LH, DGX, BRLI) (F70)